Hera Med Ltd
ASX:HMD

Watchlist Manager
Hera Med Ltd Logo
Hera Med Ltd
ASX:HMD
Watchlist
Price: 0.049 AUD -2%
Market Cap: AU$56.6m

Hera Med Ltd
Cash

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Hera Med Ltd
Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
Hera Med Ltd
ASX:HMD
Cash
$1.4m
CAGR 3-Years
-19%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inmode Ltd
NASDAQ:INMD
Cash
$169.2m
CAGR 3-Years
31%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Cash
$71m
CAGR 3-Years
-5%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
A
Alpha Tau Medical Ltd
NASDAQ:DRTS
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hera Med Ltd
Glance View

Market Cap
56.6m AUD
Industry
Health Care

HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The firm also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.

HMD Intrinsic Value
0.001 AUD
Overvaluation 98%
Intrinsic Value
Price AU$0.049

See Also

What is Hera Med Ltd's Cash?
Cash
1.4m USD

Based on the financial report for Dec 31, 2025, Hera Med Ltd's Cash amounts to 1.4m USD.

What is Hera Med Ltd's Cash growth rate?
Cash CAGR 5Y
-6%

Over the last year, the Cash growth was -56%. The average annual Cash growth rates for Hera Med Ltd have been -19% over the past three years , -6% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett